Managers / Q4 2022
Chubb Ltd
CIK 0000896159 · BARENGASSE 32, ZURICH, V8, CH-8001 · 41 0 43 456 7600
Summary
Chubb Ltd reported $30M in U.S.-listed holdings across 3 positions for Q4 2022.
The portfolio is heavily concentrated: Grab alone accounts for 68.3% of reported value.
The book was largely unchanged from Q3 2022.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 99.0% · $30M
- Common Stock · 1.0% · $312,231
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GRAB HOLDINGS LTD CL A | HELD | +0 | 6.34M | +$4M | $20M |
| NU HOLDINGS LTD CAYMAN ISL A | HELD | +0 | 2.25M | −$742,500 | $9M |
| PTCTPTC THERAPEUTICS INC | HELD | +0 | 8.2K | −$98,769 | $312,231 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | GRAB HOLDINGS LTD CL A | Com | 68.33% | $20M | 6.34M |
| 2 | NU HOLDINGS LTD CAYMAN ISL A | Com | 30.63% | $9M | 2.25M |
| 3 | PTCTPTC THERAPEUTICS INChistory → | Com | 1.04% | $312,231 | 8.2K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2022 | $30M | 3 | Feb 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $27M | 3 | Nov 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $25M | 3 | Aug 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $40M | 4 | May 6, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | Under review | 2 | Feb 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | Under review | 1 | Nov 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $28M | 3 | Aug 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $35M | 2 | May 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $107M | 3 | Feb 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $5M | 3 | Oct 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $28M | 4 | Aug 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $20M | 3 | Apr 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $23M | 4 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $22M | 4 | Nov 6, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $20M | 4 | Aug 7, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $149M | 21 | Apr 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $138M | 23 | Feb 8, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.